TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 32069121

Group type: EXPERIMENTAL
Intervention: FIO2 0.12
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: FIO2 0.145
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: FIO2 0.17
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: FIO2 0.21
Number of subjects: 12
Study: 35502412

Group type: EXPERIMENTAL
Intervention: Shugan Jianpi recipe combined with cross moxibustion
Number of subjects: 60

Group type: COMPARATOR
Intervention: Chang Shugan Jianpi recipe
Number of subjects: 60
Study: 35178737

Group type: EXPERIMENTAL
Intervention: Promotora de Salud program
Number of subjects: 0

Group type: COMPARATOR
Intervention: Standard education group
Number of subjects: 0
Study: 34628908

Group type: EXPERIMENTAL
Intervention: Nurse-led early rehabilitation program
Number of subjects: 80

Group type: COMPARATOR
Intervention: Conventional care
Number of subjects: 80
Study: 32889867

Group type: EXPERIMENTAL
Intervention: Sirolimus for ≥3 months after LT for HCC
Number of subjects: 508

Group type: EXPERIMENTAL
Intervention: Sirolimus for ≥3 months after LT for HCC in patients with AFP ≥10 ng/mL
Number of subjects: 508
Study: 36119938

Group type: EXPERIMENTAL
Intervention: Protective motivation intervention nursing
Number of subjects: 60
Study: 33994886

Group type: EXPERIMENTAL
Intervention: CN injection group
Number of subjects: 108

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 108

Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 108
Study: 32924553

Group type: EXPERIMENTAL
Intervention: Acupuncture Therapy (AT)
Number of subjects: 855

Group type: EXPERIMENTAL
Intervention: Massage Therapy (MT)
Number of subjects: 855
Study: 35581169

Group type: EXPERIMENTAL
Intervention: Adolescent-focused Cash Plus intervention (12-session course + 9 months of mentoring, productive grants, and strengthened health services)
Number of subjects: 2458

Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 2458
Study: 34075857

Group type: EXPERIMENTAL
Intervention: Mixed-method recovery intervention (MMR) consisting of active recovery, stretching, cold-water immersion, and massage
Number of subjects: 9

Group type: COMPARATOR
Intervention: Passive recovery (PAS)
Number of subjects: 9
Study: 33164729

Group type: EXPERIMENTAL
Intervention: Contraception Choices website
Number of subjects: 927

Group type: COMPARATOR
Intervention: Control group (standard care)
Number of subjects: 927
Study: 35639946

Group type: EXPERIMENTAL
Intervention: Rectus sheath infiltration with bupivacaine
Number of subjects: 150

Group type: COMPARATOR
Intervention: No infiltration
Number of subjects: 150

Group type: COMPARATOR
Intervention: Subcutaneous infiltration
Number of subjects: 150

Group type: EXPERIMENTAL
Intervention: All groups (no infiltration, subcutaneous infiltration, rectus sheath infiltration)
Number of subjects: 150
Study: 34184312

Group type: EXPERIMENTAL
Intervention: Transmuscular quadratus lumborum block with liposomal bupivacaine
Number of subjects: 92

Group type: COMPARATOR
Intervention: Standard care (control group)
Number of subjects: 92
Study: 32154936

Group type: EXPERIMENTAL
Intervention: Ticagrelor plus aspirin (90 mg twice daily plus 100 mg once daily)
Number of subjects: 231

Group type: EXPERIMENTAL
Intervention: Ticagrelor alone (90 mg twice daily)
Number of subjects: 231

Group type: EXPERIMENTAL
Intervention: Aspirin alone (100 mg once daily)
Number of subjects: 231

Group type: COMPARATOR
Intervention: All groups combined
Number of subjects: 231
Study: 34365456

Group type: EXPERIMENTAL
Intervention: Cold atmospheric plasma (CAP) wound dressing
Number of subjects: 10

Group type: COMPARATOR
Intervention: Conventional therapy
Number of subjects: 10
Study: 32475312

Group type: EXPERIMENTAL
Intervention: Sodium reduction with slow sodium tablets for 6 weeks
Number of subjects: 145

Group type: COMPARATOR
Intervention: Placebo tablets for 6 weeks
Number of subjects: 145

Group type: EXPERIMENTAL
Intervention: Sodium reduction in females
Number of subjects: 145

Group type: EXPERIMENTAL
Intervention: Sodium reduction in males
Number of subjects: 145
Study: 35084912

Group type: EXPERIMENTAL
Intervention: Cannabis users (n = 25)
Number of subjects: 47

Group type: COMPARATOR
Intervention: Non-cannabis users (n = 22)
Number of subjects: 47

Group type: EXPERIMENTAL
Intervention: Cannabis use days and cannabis use disorder symptoms
Number of subjects: 47
Study: 34138875

Group type: EXPERIMENTAL
Intervention: Group Problem Management Plus (PM+), a psychological treatment of 5 weekly sessions
Number of subjects: 611

Group type: EXPERIMENTAL
Intervention: Group Problem Management Plus (PM+)
Number of subjects: 611

Group type: COMPARATOR
Intervention: Enhanced usual care (EUC)
Number of subjects: 611
Study: 33357420

Group type: COMPARATOR
Intervention: Intravenous pertuzumab (840 mg loading dose, followed by 420 mg maintenance doses) plus intravenous trastuzumab (8 mg/kg loading dose, followed by 6 mg/kg maintenance doses)
Number of subjects: 500

Group type: EXPERIMENTAL
Intervention: Fixed-dose combination of pertuzumab and trastuzumab for subcutaneous injection (1200 mg pertuzumab plus 600 mg trastuzumab loading dose, followed by 600 mg pertuzumab plus 600 mg trastuzumab maintenance doses)
Number of subjects: 500
Study: 32688414

Group type: EXPERIMENTAL
Intervention: Multi-joint to single-joint order (MJ-SJ)
Number of subjects: 45

Group type: EXPERIMENTAL
Intervention: Single-joint to multi-joint order (SJ-MJ)
Number of subjects: 45

Group type: EXPERIMENTAL
Intervention: Alternating between upper and lower body order (ALT)
Number of subjects: 45
Study: 35268033

Group type: EXPERIMENTAL
Intervention: Mediterranean-style diet
Number of subjects: 50

Group type: COMPARATOR
Intervention: Western diet
Number of subjects: 50
Study: 33592837

Group type: EXPERIMENTAL
Intervention: rESWT on acupuncture points during the follicular phase (Group A, n=15)
Number of subjects: 44

Group type: EXPERIMENTAL
Intervention: rESWT on acupuncture points during the luteal phase (Group B, n=14)
Number of subjects: 44

Group type: COMPARATOR
Intervention: Heat patch on acupuncture points during the follicular phase (Group C, n=15)
Number of subjects: 44
Study: 33092583

Group type: EXPERIMENTAL
Intervention: PBL-CBL teaching method
Number of subjects: 586

Group type: COMPARATOR
Intervention: Traditional lecture-based classroom group
Number of subjects: 586
Study: 35943897

Group type: EXPERIMENTAL
Intervention: hsCRP (high-sensitivity C-reactive protein)
Number of subjects: 9151

Group type: EXPERIMENTAL
Intervention: IL-6 (interleukin-6)
Number of subjects: 9151

Group type: EXPERIMENTAL
Intervention: LDL-C (low-density lipoprotein cholesterol)
Number of subjects: 9151

Group type: EXPERIMENTAL
Intervention: non-HDL-C (non-high-density lipoprotein cholesterol)
Number of subjects: 9151

Group type: EXPERIMENTAL
Intervention: hsCRP
Number of subjects: 9151

Group type: EXPERIMENTAL
Intervention: IL-6
Number of subjects: 9151

Group type: EXPERIMENTAL
Intervention: LDL-C
Number of subjects: 9151

Group type: EXPERIMENTAL
Intervention: non-HDL-C
Number of subjects: 9151
Study: 34323282

Group type: COMPARATOR
Intervention: Direct ET
Number of subjects: 352

Group type: EXPERIMENTAL
Intervention: Afterload ET
Number of subjects: 352
Study: 32724270

Group type: EXPERIMENTAL
Intervention: Standard Automated Perimetry (SAP)
Number of subjects: 180

Group type: EXPERIMENTAL
Intervention: Frequency Doubling Technology (FDT)
Number of subjects: 180

Group type: COMPARATOR
Intervention: Diabetic patients
Number of subjects: 180

Group type: COMPARATOR
Intervention: Healthy subjects
Number of subjects: 180
Study: 35187687

Group type: EXPERIMENTAL
Intervention: Centre-near multifocal soft contact lenses with a 2.00 D add for 2 years
Number of subjects: 22

Group type: COMPARATOR
Intervention: Single vision spectacles
Number of subjects: 22
Study: 33819178

Group type: EXPERIMENTAL
Intervention: PXVX0200
Number of subjects: 73
Study: 34475522

Group type: EXPERIMENTAL
Intervention: 125 mg of saracatinib
Number of subjects: 43

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 43
Study: 34475898

Group type: EXPERIMENTAL
Intervention: Non-operative treatment (NOT) with intravenous Meropenem and Metronidazole for 48 hours followed by oral antibiotics for 7 days (Group A)
Number of subjects: 180

Group type: COMPARATOR
Intervention: Appendectomy (Group B)
Number of subjects: 180

Group type: EXPERIMENTAL
Intervention: Non-operative treatment (NOT) with failure
Number of subjects: 180
Study: 34413344

Group type: EXPERIMENTAL
Intervention: SCP-NF
Number of subjects: 67

Group type: EXPERIMENTAL
Intervention: fNIRS-NF
Number of subjects: 67

Group type: COMPARATOR
Intervention: EMG-BF
Number of subjects: 67
Study: 32950728

Group type: EXPERIMENTAL
Intervention: 38 % SDF and potassium iodide (KI)
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Conditioner polyacrylic acid (PAA)
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: 38 % SDF
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Photodynamic therapy (PDT)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Untreated (control group)
Number of subjects: 60
Study: 35081671

Group type: EXPERIMENTAL
Intervention: Systems Training for Emotional Predictability and Problem Solving (STEPPS) program
Number of subjects: 164

Group type: EXPERIMENTAL
Intervention: High severity (HS) class (26%)
Number of subjects: 164

Group type: EXPERIMENTAL
Intervention: Affective instability/substance abuse (AISA) class (16%)
Number of subjects: 164

Group type: EXPERIMENTAL
Intervention: Empty/dissociation/identity disturbance (EDID) class (27%)
Number of subjects: 164

Group type: EXPERIMENTAL
Intervention: Low severity (LS) class (30%)
Number of subjects: 164
Study: 33969450

Group type: EXPERIMENTAL
Intervention: UV-irradiated implants
Number of subjects: 34

Group type: COMPARATOR
Intervention: Conventional commercial implants
Number of subjects: 34
Study: 32408374

Group type: EXPERIMENTAL
Intervention: Observational studies in homeopathy
Number of subjects: 0

Group type: COMPARATOR
Intervention: Not applicable
Number of subjects: 0
Study: 35801618

Group type: EXPERIMENTAL
Intervention: High-intensity focused ultrasound (HIFU) treatment by inexperienced physicians
Number of subjects: 720

Group type: COMPARATOR
Intervention: High-intensity focused ultrasound (HIFU) treatment by experienced physicians
Number of subjects: 720

Group type: EXPERIMENTAL
Intervention: Learning group (inexperienced physicians)
Number of subjects: 720

Group type: COMPARATOR
Intervention: Control group (experienced physicians)
Number of subjects: 720
Study: 32345329

Group type: EXPERIMENTAL
Intervention: PE + Peer Support (in vivo peer support during homework for 3-4 weeks)
Number of subjects: 150

Group type: COMPARATOR
Intervention: PE + Peer Support (weekly peer calls for 3-4 weeks)
Number of subjects: 150
Study: 36484087

Group type: EXPERIMENTAL
Intervention: Cerec™ software (CR)
Number of subjects: 95

Group type: EXPERIMENTAL
Intervention: PrepCheck™ software (PC)
Number of subjects: 95

Group type: COMPARATOR
Intervention: Silicon keys (C)
Number of subjects: 95
Study: 32540179

Group type: EXPERIMENTAL
Intervention: ADAPT system
Number of subjects: 102

Group type: COMPARATOR
Intervention: Conventional method
Number of subjects: 102
Study: 35850010

Group type: EXPERIMENTAL
Intervention: Cardiac Troponins (hs-cTnI, hs-cTnT) and NT-proBNP
Number of subjects: 4102

Group type: COMPARATOR
Intervention: Cardiac markers (hs-cTnI, hs-cTnT, NT-proBNP)
Number of subjects: 4102
Study: 34879499

Group type: EXPERIMENTAL
Intervention: Hydroxyzine
Number of subjects: 140

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 140
Study: 33573766

Group type: EXPERIMENTAL
Intervention: Forecasting Your Future: Nutrition Matters training
Number of subjects: 35

Group type: COMPARATOR
Intervention: Control group (usual curriculum)
Number of subjects: 35
Study: 32945898

Group type: EXPERIMENTAL
Intervention: GH
Number of subjects: 9

Group type: EXPERIMENTAL
Intervention: GH+acipimox
Number of subjects: 9

Group type: EXPERIMENTAL
Intervention: acipimox
Number of subjects: 9

Group type: COMPARATOR
Intervention: control
Number of subjects: 9
Study: 34125980

Group type: EXPERIMENTAL
Intervention: Cigarette smoke extract (CSE) treatment in 16HBE cells
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: LUCAT1 silencing
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: miR‐181a‐5p inhibition
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: LUCAT1 expression
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: LUCAT1
Number of subjects: 0
Study: 35442091

Group type: EXPERIMENTAL
Intervention: Fluoride varnish (FV) applied at 6-month intervals
Number of subjects: 534

Group type: COMPARATOR
Intervention: Treatment as usual (TAU) - multicomponent national child oral health improvement intervention (Childsmile program) excluding nursery FV
Number of subjects: 534
Study: 34229624

Group type: EXPERIMENTAL
Intervention: Innovative electronic trial recruitment and outcomes software
Number of subjects: 16

Group type: COMPARATOR
Intervention: External IT support
Number of subjects: 16

Group type: COMPARATOR
Intervention: Approval processes for new software
Number of subjects: 16
Study: 32611327

Group type: EXPERIMENTAL
Intervention: Postoperative adjuvant radiotherapy (RT) in addition to standard postoperative treatment of HBV/HCV and nutritional therapy
Number of subjects: 59

Group type: COMPARATOR
Intervention: Standard postoperative treatment of HBV/HCV and nutritional therapy (Control)
Number of subjects: 59

Group type: EXPERIMENTAL
Intervention: Postoperative adjuvant radiotherapy (RT)
Number of subjects: 59
Study: 34320659

Group type: EXPERIMENTAL
Intervention: High-intensity interval training (HIIT)
Number of subjects: 30
Study: 34219633

Group type: EXPERIMENTAL
Intervention: Arabin pessary plus standard care
Number of subjects: 503

Group type: COMPARATOR
Intervention: Standard care alone
Number of subjects: 503
Study: 32709514

Group type: EXPERIMENTAL
Intervention: Thrust Joint Manipulation (TJM)
Number of subjects: 67

Group type: COMPARATOR
Intervention: Sham Manipulation
Number of subjects: 67
Study: 35588750

Group type: EXPERIMENTAL
Intervention: TIPS plus embolisation
Number of subjects: 134

Group type: COMPARATOR
Intervention: TIPS
Number of subjects: 134
Study: 33896733

Group type: EXPERIMENTAL
Intervention: Simulation training (postsimulation group)
Number of subjects: 28

Group type: COMPARATOR
Intervention: No simulation training (presimulation group)
Number of subjects: 28

Group type: COMPARATOR
Intervention: Additional mid-rotation simulation training
Number of subjects: 28
Study: 32119093

Group type: EXPERIMENTAL
Intervention: Smartphone coaching app plus home blood pressure monitor
Number of subjects: 333

Group type: COMPARATOR
Intervention: Blood pressure tracking app plus home blood pressure monitor
Number of subjects: 333
Study: 36297080

Group type: EXPERIMENTAL
Intervention: L-Citrulline (10 g)
Number of subjects: 25

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 25
Study: 33993905

Group type: EXPERIMENTAL
Intervention: Secukinumab 300 mg
Number of subjects: 1049

Group type: EXPERIMENTAL
Intervention: Secukinumab 150 mg
Number of subjects: 1049

Group type: EXPERIMENTAL
Intervention: Secukinumab 75 mg
Number of subjects: 1049

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 1049

Group type: EXPERIMENTAL
Intervention: All treatment groups (Secukinumab 75 mg, 150 mg, 300 mg)
Number of subjects: 1049
Study: 32938481

Group type: EXPERIMENTAL
Intervention: Enhanced‐Assisted Feedback arm
Number of subjects: 106

Group type: COMPARATOR
Intervention: Basic arm
Number of subjects: 106
Study: 35581905

Group type: EXPERIMENTAL
Intervention: Combination therapy with pioglitazone plus exenatide
Number of subjects: 0

Group type: COMPARATOR
Intervention: Insulin therapy or metformin sequentially followed by glipizide and basal insulin
Number of subjects: 0
Study: 34737792

Group type: EXPERIMENTAL
Intervention: Ticagrelor
Number of subjects: 270

Group type: COMPARATOR
Intervention: Clopidogrel
Number of subjects: 270
Study: 33371197

Group type: EXPERIMENTAL
Intervention: Health warning message using red road traffic stop sign ('Stop')
Number of subjects: 78

Group type: EXPERIMENTAL
Intervention: Health warning message using shocking pictures ('Shock')
Number of subjects: 78

Group type: COMPARATOR
Intervention: Sweets without warning messages
Number of subjects: 78
Study: 36482600

Group type: EXPERIMENTAL
Intervention: Warm acupuncture
Number of subjects: 0

Group type: COMPARATOR
Intervention: Conventional Western medicine
Number of subjects: 0
Study: 33420717

Group type: EXPERIMENTAL
Intervention: Group-based education program (three sessions)
Number of subjects: 130
Study: 34784547

Group type: EXPERIMENTAL
Intervention: Omalizumab add-on therapy
Number of subjects: 0

Group type: COMPARATOR
Intervention: Standard of Care (SoC) alone
Number of subjects: 0
Study: 33647580

Group type: EXPERIMENTAL
Intervention: Cognitive‐behavioral group therapy (CBGT)
Number of subjects: 108

Group type: EXPERIMENTAL
Intervention: Mindfulness‐based stress reduction (MBSR)
Number of subjects: 108

Group type: COMPARATOR
Intervention: Waitlist (WL)
Number of subjects: 108
Study: 33684919

Group type: EXPERIMENTAL
Intervention: High-dose GH (100 μg/kg/day)
Number of subjects: 35

Group type: EXPERIMENTAL
Intervention: Standard-dose GH (33 μg/kg/day)
Number of subjects: 35

Group type: EXPERIMENTAL
Intervention: Low-dose GH (11 μg/kg/day)
Number of subjects: 35
Study: 35622140

Group type: EXPERIMENTAL
Intervention: Monofocal with enhanced intermediate vision lens
Number of subjects: 60

Group type: COMPARATOR
Intervention: Standard monofocal lens
Number of subjects: 60
Study: 33418483

Group type: EXPERIMENTAL
Intervention: Active tDCS (1.7 mA, 20 min; n = 27)
Number of subjects: 49

Group type: COMPARATOR
Intervention: Sham tDCS (1.7 mA, 30 s; n = 22)
Number of subjects: 49
Study: 35932476

Group type: EXPERIMENTAL
Intervention: Low energy density (0.09 mJ/mm2)
Number of subjects: 51

Group type: EXPERIMENTAL
Intervention: Medium energy density (0.18 mJ/mm2)
Number of subjects: 51

Group type: EXPERIMENTAL
Intervention: High energy density (0.38 mJ/mm2)
Number of subjects: 51
Study: 33256192

Group type: EXPERIMENTAL
Intervention: Fluoride gel
Number of subjects: 7

Group type: EXPERIMENTAL
Intervention: Nd:YAG radiation combined with fluoride gel
Number of subjects: 7

Group type: COMPARATOR
Intervention: Verbal rating scale (VRS)
Number of subjects: 7
Study: 32430775

Group type: EXPERIMENTAL
Intervention: TePe EasyPick™ (SCIP)
Number of subjects: 30

Group type: COMPARATOR
Intervention: TePe Interdental Brushes Original (IDB)
Number of subjects: 30
Study: 35253684

Group type: EXPERIMENTAL
Intervention: Rotating Shiftwork Questionnaire (RSQ)
Number of subjects: 18
Study: 34465476

Group type: EXPERIMENTAL
Intervention: IgG antibodies against pertussis toxin (PT) measured with the CDC/FDA ELISA
Number of subjects: 1581

Group type: COMPARATOR
Intervention: EUROIMMUN test
Number of subjects: 1581
Study: 34843380

Group type: EXPERIMENTAL
Intervention: Sleeve Gastrectomy (SG)
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: Roux-en-Y Gastric Bypass (RYGB)
Number of subjects: 100

Group type: COMPARATOR
Intervention: Both SG and RYGB
Number of subjects: 100
Study: 32446176

Group type: EXPERIMENTAL
Intervention: safinamide 50 mg/day (S50)
Number of subjects: 406

Group type: EXPERIMENTAL
Intervention: safinamide 100 mg/day (S100)
Number of subjects: 406

Group type: COMPARATOR
Intervention: Placebo (P)
Number of subjects: 406
Study: 33031517

Group type: EXPERIMENTAL
Intervention: V160 vaccine
Number of subjects: 0
Study: 32036693

Group type: EXPERIMENTAL
Intervention: Secretin
Number of subjects: 20

Group type: COMPARATOR
Intervention: Placebo (saline)
Number of subjects: 20
Study: 34173895

Group type: EXPERIMENTAL
Intervention: Act Healthy (AH)
Number of subjects: 61

Group type: COMPARATOR
Intervention: Supportive counseling (SC) plus Life-Steps medication adherence counseling
Number of subjects: 61

Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 61
Study: 34847226

Group type: EXPERIMENTAL
Intervention: Calcium (5 mmol of calcium chloride, n=197)
Number of subjects: 397

Group type: COMPARATOR
Intervention: Saline (n=200)
Number of subjects: 397
Study: 36219589

Group type: EXPERIMENTAL
Intervention: Educational intervention using printed message cards about the quadrivalent HPV vaccine (n = 118)
Number of subjects: 238

Group type: COMPARATOR
Intervention: Routine instructions (Control group, n = 120)
Number of subjects: 238
Study: 33797635

Group type: EXPERIMENTAL
Intervention: Highly filled flowable composite Clearfil Majesty ES Flow (ES, n = 42)
Number of subjects: 27

Group type: COMPARATOR
Intervention: Conventional paste-type composite Majesty (MJ, n = 42)
Number of subjects: 27
Study: 35815478

Group type: EXPERIMENTAL
Intervention: Tricalcium silicate (TCS) paste
Number of subjects: 45

Group type: EXPERIMENTAL
Intervention: Casein phosphopeptide amorphous calcium phosphate (CPP-ACP)
Number of subjects: 45

Group type: EXPERIMENTAL
Intervention: Silver diamine fluoride potassium iodide (SDF-KI)
Number of subjects: 45

Group type: COMPARATOR
Intervention: SDF-KI
Number of subjects: 45

Group type: COMPARATOR
Intervention: CPP-ACP
Number of subjects: 45
Study: 32419645

Group type: EXPERIMENTAL
Intervention: ColdZyme Mouth Spray
Number of subjects: 123

Group type: EXPERIMENTAL
Intervention: ColdZyme Mouth Spray (good compliance)
Number of subjects: 123

Group type: EXPERIMENTAL
Intervention: ColdZyme Mouth Spray (poor compliance)
Number of subjects: 123

Group type: COMPARATOR
Intervention: Control (no treatment)
Number of subjects: 123

Group type: EXPERIMENTAL
Intervention: ColdZyme Mouth Spray (overall)
Number of subjects: 123

Group type: COMPARATOR
Intervention: Control (overall)
Number of subjects: 123
Study: 32925811

Group type: EXPERIMENTAL
Intervention: Semi-automatic stapler
Number of subjects: 664

Group type: COMPARATOR
Intervention: Needle (conventional thread)
Number of subjects: 664
Study: 35090529

Group type: EXPERIMENTAL
Intervention: Curcumin and zinc co-supplementation
Number of subjects: 84

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 84
Study: 34105688

Group type: EXPERIMENTAL
Intervention: Telephone intervention
Number of subjects: 208

Group type: COMPARATOR
Intervention: Group education
Number of subjects: 208

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 208
Study: 34898069

Group type: EXPERIMENTAL
Intervention: Prostatic massage twice a week (Group A)
Number of subjects: 76

Group type: EXPERIMENTAL
Intervention: Biofeedback and electrical stimulation 5 times a week (Group B)
Number of subjects: 76

Group type: EXPERIMENTAL
Intervention: Biofeedback and electrical stimulation 5 times a week combined with prostatic massage twice a week (Group C)
Number of subjects: 76

Group type: COMPARATOR
Intervention: Control group (Group D)
Number of subjects: 76
Study: 34337917

Group type: EXPERIMENTAL
Intervention: As needed propofol administration
Number of subjects: 32

Group type: COMPARATOR
Intervention: Continuous infusion of propofol (5 mg kg‐1 h‐1)
Number of subjects: 32
Study: 33790049

Group type: EXPERIMENTAL
Intervention: Methylprednisolone and tocilizumab (if necessary) in addition to optimal supportive care
Number of subjects: 172

Group type: COMPARATOR
Intervention: Optimal supportive care only
Number of subjects: 172